Learn about the four-part video course by self-storage industry owner and builder Charlie Kao on how to conduct feasibility research, make assessments, manage assumptions and more.
The RootsTech On-Demand Library lets you access 1500 videos even if you can’t make it to Salt Lake City for the big event. Here are some tips for navigating it.
them. we can put up on screen one of the promos that shows interview club. this is an example of what you can t do on normal tv but can do online. is that the idea for cnn plus, figure out what we can do differently with the technology available today? it s right at the part heart of what cnn plus s it has to be different, has to be distinctive. the cnn television channel actually all four of our cnn television channels are incredibly important to users and cnn.com is as well. with cnn plus having live programming and a massive on demand library and this interactive platform gives users something that doesn t exist. it is truly unique. here is interview club now. you can log in, write a question in the corner of the screen and then those questions will get fed to the hosts and be answered by experts. so you can imagine situations where doctors and other medical experts are able to answer questions about the pandemic, for example. so there s three buckets, basically, live, on dema
Share this article
Share this article
SAN DIEGO, March 12, 2021 /PRNewswire/ Angiocrine Bioscience Inc., a clinical-stage biopharmaceutical company today announced that they have been selected by the European Society for Blood and Marrow Transplantation (EBMT) for an oral presentation of from AB-205-001, a Phase 1b/2 study to prevent progression to severe organ toxicities in lymphoma subjects undergoing curative high-dose consolidation therapy with autologous hematopoietic cell transplantation (HDT-AHCT). Our investigators and Angiocrine are honored to be selected by EBMT to present at its annual meeting this March, commented Paul Finnegan, MD, Angiocrine CEO. We look forward to Dr. Caroline Mulroney s presentation of AB-205 s efficacy and safety results from our Phase 1b/2 study as well as preparing for the upcoming Phase 3 registration study for this indication.
Angiocrine Bioscience Announces Oral Presentation of AB-205 Data during the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.